Rumble's stock price (NASDAQ: RUM) has once again tested $11 resistance, with bulls looking to set up a rally, before the fading on the day to close below $10 at $9.89. Despite the wild intraday swing, 1.64% to start the week

BT's share price (LON:BT-A) has hit the psychologically significant 200p mark today, making a new 52 week high at 200.60p, before closing out the day just below at 198.80, for a 0.43% gain. The shares have had a very strong 2

Northrop Grumman Corporation (NYSE: NOC) prepares to unveil earnings before the market opens tomorrow morning, with the stock moving ever closer to resistance. The firm's performance will not only be watched by its own shareh

Coca-Cola's stock(NYSE: KO)is holding firm above $70 leading into earnings, having carved out gains of 13% since the start of the year. While the beverage giant’s historical resilience and brand recognition remain formidable

JD.com has seen it's stock price (NASDAQ: JD) target trimmed today, despite the analyst keeping in place a bullish outlook. The stock is trading at $33.34, down 1.6% on the day, having previously adding 10% in the last week.

Block's stock price (NYSE: XYZ)is on the move this morning, up 9.42%, rising $6.86 to $79.68 ahead of the market open. The fintech firm has been given a huge boost, with the stock set for inclusion in the S&P 500 index.

LexinFintech Holdings stock (NASDAQ: LX) is on the move pre-market, trading up 9.35% as a newly authorized $50 million share repurchase program and substantial insider buying by the company's Chief Executive Officer boosts se

Pinterest's stock price (NASDAQ: PINS) is generating significant buzz on Wall Street, up 5% in the pre-market with a recent upgrade from Morgan Stanley projecting substantial gains for stock. The investment bank moved its rat

Verizon's stock (VZ) is trading 4.75% higher this morning, as second-quarter earnings came in strong, outperforming the street. The firm reported revenue of $34.5 billion,

Despite Netflix's stock (NFLX) dipping by 5.10% following Q2 2025 earnings release, multiple analysts have raised their price targets, reflecting continued confidence in the company's long-term growth trajectory.

Stellantis' stock price (NYSE: STLA) failed at the latest attempt to hold $10, with a 7.72% in last week looking to be get worse in pre-market trading after the automotive giant released preliminary figures projecting a net l

Reddit's stock (RDDT) has been given a boost by Wall Street, with a bullish upgrade from Morgan Stanley coming off the back of a 4% gain in the most recent session. The firm raised its price target for RDDT to $170 from $154,

Navitas Semiconductor's stock price (NASDAQ: NVTS) has had a meteoric rise this year, with strategic partnerships and industry tailwinds boosting NVTS to a double up YTD. The question now is whether NVTS may be primed for ano

Microsoft (NASDAQ: MSFT) reported an urgent alert regarding active "zero-day" attacks targeting on-premise SharePoint servers, software widely used by government agencies and businesses for internal document sharing over the

Meta Platforms' stock (NASDAQ: META) has been given a vote of confidence, with a significant analyst upgrade over the weekend, which alongside ambitious AI investme

Ryanair (RYAAY) has delivered an earnings report that has left analysts both impressed and cautiously optimistic. The budget airline powerhouse announced a profit after ta

GSK (LON: GSK) shares face growing caution from analysts ahead of the company’s second-quarter results on July 30, with Morgan Stanley and Berenberg both recently tempering expectations for the stock.

Barclays (LON: BARC) shares have rallied significantly over the last year or so, but according to analysts at Citi, the uptrend may come under pressure.  Citi downgrad

Robinhood's stock price (NASDAQ: HOOD) has been busy setting new all-time highs today at $113.44, and currently trades up 5.85%. This bullish momentum, building on weeks of impressive gains, has been pushed along by growing i

GlaxoSmithKline share price (LON:GSK) is down 4% today, weighing on the Footsie as the FSA's advisory panel voted against approving Blenrep (belantamab mafodotin-blmf